Bone mass, bone turnover, vitamin D, and estrogen receptor gene polymorphisms in male to female transsexuals: Effects of estrogenic treatment on bone metabolism of the male

Journal of Clinical Densitometry

Volumn 6, Issue 3, 2003, Pages 297-304

  Sosa, Manuel ^a,b   Jódar, Esteban ^c   Arbelo, Elena ^a   Domínguez, Casimira ^d   Saavedra, Pedro ^a   Torres, Armando ^e   Salido, Eduardo ^e   Gómez De Tejada, María Jesús ^f   Hernández, Diego ^b  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b Insular Hospital   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e UNIVERSIDAD DE LA LAGUNA   (Spain)

^f UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Bone mineral density; Bone remodeling markers; Calciotropic hormones; Estrogens; Estrogens in males; Transsexuals

Indexed keywords

BIOCHEMICAL MARKER; CONJUGATED ESTROGEN; CONTRACEPTIVE AGENT; DIANE; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ESTROGEN RECEPTOR; ETHINYLESTRADIOL PLUS LEVONORGESTREL; HORMONE; MESTRANOL PLUS NORETHISTERONE; TESTOSTERONE; VITAMIN D RECEPTOR;

ADULT; ARTICLE; BIOCHEMISTRY; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMUR NECK; HORMONAL REGULATION; HUMAN; LONG TERM EXPOSURE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEX HORMONE DETERMINATION; SHORT STATURE; TESTOSTERONE BLOOD LEVEL; TRANSSEXUALISM;

EID: 0141636356     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1385/JCD:6:3:297     Document Type: Article

References (26)

1. World Health Organisation. 1994 Assessment of fractures risk in screening for osteoporosis. WHO technical report series 843. Geneva: WHO.
2. Cummings SR, Kelsey JL, Newitt MC, O'Dowd KJ. 1985 Epidemiology of osteoporotic fractures. Epidemiol Rev 7:178-208.
3. Obrant KJ, Bengner U, Johnell O, Nilsson BE, Sernbo I. 1989 Increasing age-adjusted risk of fragility fractures: a sign of increasing osteoporosis in successive generations? Calcif Tissue Int 44:157-167.
4. Kanis JHA, Pitt FA. 1992 The epidemiology of osteoporosis. Bone 13:S7-15.
5. Melton LJ III. 1993 Hip fractures: a worldwide problem today and tomorrow. Bone 14:S1-8.
6. Ray NF, Chan JK, Thamer M, Melton LJ III. 1997 Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24-35.
7. Cooper C, Campion G, Melton LJ III. 1992 Hip fractures in the elderly: a worldwide projection. Osteoporos Int 2:285-9.
8. Cooper C, O'Neill T, Silman A on behalf of the European Vertebral Osteoporosis Study Group (EVOS). 1993 The Epidemiology of Vertebral fractures. Bone 14:589-597.
9. Albright F, Reifenstein EC. 1948 The parathyroid glands and metabolic bone disease. Selected studies. Baltimore, MD, Williams & Wilkins Co pp. 145-204.
10. Compston J. 2001 Secondary causes of osteoporosis in men. Calcif Tissue Int 69:193-195
11. Zachmann M, Prader A, Sobel EH, Crigler Jr JF, Ritzen EM, Atares M, et al. 1986 Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogens in pubertal growth. J Pediatrics 108:694-697.
12. Smith EP, Boyd J, Frank GR, Takahishi H, Cohen RM, Specker B, et al. 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061.
13. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. 1994 A syndrome of females pseudohermaphroditism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutation in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 78:1287-1292.
14. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, et al. 1997 Effects od testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91-95.
15. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, et al. 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730.
16. Carlström K, Stege R, Henriksson P, Granado M, Gunnarsson PO, Pousette A. 1997 Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orquidectomy in the treatment of patients with prostatic carcinoma. Prostate 31:193-197.
17. van Kesteren P, Lips P, Gooren JG, Asscheman H, Megens J. 1998 Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol 48:347-354.
18. Reutrakul S, Ongphiphadhanakul B, Piaseu N, Krittiyawong S, Chanprasertyothin S, Bunnag P, et al. 1998 The effects of oestrogen exposure on bone mass in male to female transsexuals. Clin Endocrinol 49:811-814.
19. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. 2000 Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553-1560.
20. Grupo de trabajo sobre protocolos y práctica clínica SEIOMM. 2000 Datos básicos en osteoporosis. Rev Esp Enf Metab Óseas 9:84-85.
21. Sosa M, Hernández D, Estévez S, Rodríguez M, Limiñana, JM, Saavedra P, et al. 1998 The range of bone mineral density in healthy Canarian women by dual X-ray absorptiometry radiography and quantitative computer tomography. J Clin Densitometry 1:385-393.
22. Díaz Curiel M, Díez Pérez A, Gómez Alonso C. 1996 Nuevas fronteras en el estudio de la densidad ósea en la población española. Madrid: Ed. FHOEMO, SEIOMM, RPR. Madrid.
23. Lindsay R. Sex steroids in the pathogenesis and prevention of osteoporosis. In: Osteoporosis: Etiology, Diagnosis, and Management pp. 333-358 Ed. Riggs, BL. New York: Raven Press, 1988.
24. Riggs BL, Khosla S, Melton LJ III. 1998 A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763-773.
25. Lips P, Asscheman H, Uitewaal P, Netelenbos JC, Gooren L. 1989 The effects of cross gender hormonal treatment on bone metabolism in male-to-female transsexuals. J Bone Miner Res 4:657-662.
26. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseu N, Chailurkit L. 1998 Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol 49:803-809.